📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ambroxol reverses tau and a-synuclein accumulation in a cholinergic N370S GBA1 mutation model. (2022)

First Author: Yang SY

Attributed to: JPND GBA - personalised medicine for Parkinson disease: clinical and therapeutic stratification funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddac038

PubMed Identifier: 35179198

Publication URI: http://europepmc.org/abstract/MED/35179198

Type: Journal Article/Review

Volume: 31

Parent Publication: Human molecular genetics

Issue: 14

ISSN: 0964-6906